Berman Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
JSP
CIP
BCM
RI
Berman Capital Advisors's TNDM Position: Q3 2021 in Review
Berman Capital Advisors increased its Tandem Diabetes Care (TNDM) stake by 80% in Q3 2021, buying an estimated $15K and bringing the position to 306 shares worth $36K. The position accounts for 0.01% of the portfolio, ranked #805.
Berman Capital Advisors first reported a position in TNDM in Q4 2020 and has held it in 4 quarters since. 337 funds tracked by Wall St. Rank hold TNDM as of Q3 2021.
- Berman Capital Advisors held 306 shares of Tandem Diabetes Care worth $36K as of Q3 2021.
- Berman Capital Advisors bought 136 Tandem Diabetes Care shares in Q3 2021, an estimated $15K.
- Tandem Diabetes Care made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #805 holding.
- Berman Capital Advisors first reported a position in Tandem Diabetes Care in Q4 2020 and has held it in 4 quarters since.
- 337 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2021.
Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.